000 07968nam a22004573i 4500
001 EBC5087769
003 MiAaPQ
005 20240729131514.0
006 m o d |
007 cr cnu||||||||
008 240724s2017 xx o ||||0 eng d
020 _a9783319639109
_q(electronic bk.)
020 _z9783319639093
035 _a(MiAaPQ)EBC5087769
035 _a(Au-PeEL)EBL5087769
035 _a(CaPaEBR)ebr11449603
035 _a(OCoLC)1005554480
040 _aMiAaPQ
_beng
_erda
_epn
_cMiAaPQ
_dMiAaPQ
050 4 _aRC870-923.2
100 1 _aCorcos, Jacques.
245 1 0 _aConsultation in Neurourology :
_bA Practical Evidence-Based Guide.
250 _a1st ed.
264 1 _aCham :
_bSpringer International Publishing AG,
_c2017.
264 4 _c©2018.
300 _a1 online resource (310 pages)
336 _atext
_btxt
_2rdacontent
337 _acomputer
_bc
_2rdamedia
338 _aonline resource
_bcr
_2rdacarrier
505 0 _aIntro -- Foreword I -- Foreword II -- Preface -- Contents -- Part I: Introduction -- 1: Book Presentation with Overview of Bladder Physiology -- Book Presentation -- Organization of Summaries and Recommendations -- Overview of the Physiology of Lower Urinary Tract -- References -- 2: Neurogenic Bladder Pathophysiology -- Introduction -- Neurogenic Detrusor Overactivity -- Neurogenic Detrusor Underactivity -- Detrusor-Sphincter Dyssynergia -- Neurogenic Sphincter Deficiency -- Conclusion (Table 2.1) -- References -- 3: Pathologies Responsible for the Development of the Neurogenic Bladder -- Introduction -- Traumatic Entities and Their Neurourological Consequences -- Head Injury -- Spinal Cord Injury -- Non-traumatic Entities and Their Neurourological Consequences -- Suprapontine Lesion (Brain) -- Degeneration -- Infrapontine-Suprasacral Lesion (Spinal Cord) -- Sacral-Infrasacral Lesion (Spinal Cord and Peripheral Nervous System) -- Iatrogenic Causes -- Conclusion (Table 3.5) -- References -- Part II: First Consultation of Patients with Spinal Cord Injury -- 4: Medical History and Physical Examination -- Introduction -- Medical History -- Physical Examination -- Conclusion (Table 4.4) -- References -- 5: Testing -- Introduction -- Recommended Tests -- Urinalysis/Urine Culture -- Blood Chemistry -- Voiding Diary -- Post-void Residual -- Urinary Tract Ultrasound -- Elective Tests -- Urethrocystoscopy -- Computed Tomography, Magnetic Resonance Imaging, Others -- Uroflowmetry -- Urodynamic Testing -- Video-Urodynamics -- Specialist Uro-neurophysiological Tests -- Conclusion (Table 5.1) -- References -- 6: Bladder Management and Follow-Up Plan -- Introduction -- Bladder Management -- Follow-up Plan -- Conclusion (Table 6.3) -- References -- Part III: Consultations for Main Complaints in Neurogenic Bladder.
505 8 _a7: Incontinence Due to Neurogenic Detrusor Overactivity -- Introduction -- Epidemiology -- Diagnosis -- History and Physical Examination -- Bladder Diary and Questionnaires -- Urinalysis and Urine Culture -- Pad-Weighing Test -- Renal Evaluation -- Other Investigations -- Urodynamics -- Treatment -- Conservative Treatment -- Pharmacological Treatment -- Botulinum Toxin A Injections -- Neurostimulation/Neuromodulation -- Surgery -- Conclusion (Table 7.2, Fig. 7.13) -- References -- 8: Retention -- Introduction -- Epidemiology -- Diagnosis -- History and Physical Examination -- Bladder Diary and Questionnaires -- Urinalysis and Urine Culture -- Uroflowmetry -- Post-void Residual -- Renal Evaluation -- Bladder Ultrasound -- Other Investigations -- Urodynamics -- Treatment -- Treatment of Patients with Retention Due to NDU -- Treatment of Patients with Retention Due to DSD -- Special Consideration for Patients with Detrusor Hyperactivity and Impaired Contractility -- Conclusion (Table 8.2) -- References -- 9: Incontinence Due to Neurogenic Sphincter Deficiency -- Introduction -- Epidemiology -- Diagnosis -- Medical History -- Physical Examination -- Other Recommended and Elective Tests -- Urodynamics -- Treatment -- Conservative Treatment -- Surgery -- Conclusion (Table 9.1) -- References -- Part IV: Consultations for Complications of Neurogenic Bladder -- 10: Urinary Tract Infection -- Introduction -- Definitions -- Epidemiology -- Diagnosis -- Symptoms and Signs -- Laboratory Testing -- Additional Testing -- Treatment -- Prevention -- Mechanical Strategies for UTI Prevention -- Medical Strategies for UTI Prevention -- Conclusion (Table 10.1) -- References -- 11: Urolithiasis -- Introduction -- Epidemiology -- Risk Factors -- Stone Composition -- Diagnosis and Treatment -- Diagnosis -- Treatment.
505 8 _aPreoperative Considerations in Neurogenic Patients Suffering from Urolithiasis -- Treatment Options -- Prevention -- Conclusion (Table 11.1) -- References -- 12: Hydronephrosis -- Introduction -- Pathophysiology -- Diagnosis -- Medical History and Physical Examination -- Laboratory Testing -- Imaging -- Ultrasound -- Computed Tomography -- Other Techniques -- Treatment -- Drainage -- Percutaneous Nephrostomy -- Ureteral Stents -- Other -- Vesicoureteral Reflux -- Conclusion (Table 12.1) -- References -- 13: Renal Failure -- Introduction -- Epidemiology -- Diagnosis -- Chronic Kidney Disease (Chronic Renal Failure) -- Definitions and Staging -- Signs and Symptoms -- Laboratory Data -- Imaging Studies -- Acute Kidney Injury -- Definitions and Staging -- Signs and Symptoms -- Laboratory Data -- Imaging Studies -- Treatment -- Treatment of Chronic Kidney Disease -- Urinary Diversion -- Renal Replacement Therapy -- Treatment of Acute Kidney Injury -- Conclusion (Table 13.2) -- References -- 14: Autonomic Dysreflexia -- Introduction -- Pathophysiology -- Epidemiology -- Etiology -- Diagnosis -- Symptoms and Signs -- Consequences -- Treatment -- Acute Management -- Chronic Management (Prevention) -- Conclusion (Table 14.1, Fig. 14.2) -- References -- 15: Other (Bladder Cancer, Sexual Dysfunction) -- Bladder Cancer -- Epidemiology -- Risk Factors -- Screening -- Diagnosis and Treatment -- Sexual Dysfunction -- Epidemiology -- Diagnosis -- Treatment -- Management of Sexual (Erectile) Dysfunction in the Male -- Oral Pharmacological Therapy (Phosphodiesterase Type 5 Inhibitors) -- Mechanical (Vacuum Constriction) Devices -- Intracavernosal Injection Therapy -- Penile Prostheses -- Other Treatment Options -- Management of Sexual Dysfunction in the Female -- Conclusion (Table 15.1) -- References -- 16: Benign Prostatic Hyperplasia and Neurogenic Bladder.
505 8 _aIntroduction -- Epidemiology -- Diagnosis -- Treatment -- Pharmacological Treatment -- Surgical Treatment -- Other Treatment Options -- Conclusion (Table 16.1) -- References -- Part V: Patient Education -- 17: Patient Education -- Introduction -- Intermittent Catheterization -- Behavioral Techniques -- Toileting Assistance -- Pelvic Floor Muscle Therapy -- Lifestyle Intervention -- Care of Urinary Diversion -- Conclusion (Table 17.4) -- References -- Part VI: Reports and Guidelines -- 18: Reports and Guidelines on Neurogenic Bladder -- General Neurourological Guidelines -- Patients After Spinal Cord Injury -- Pediatric Patients -- Urodynamics -- Regional Guidelines -- Index.
588 _aDescription based on publisher supplied metadata and other sources.
590 _aElectronic reproduction. Ann Arbor, Michigan : ProQuest Ebook Central, 2024. Available via World Wide Web. Access may be limited to ProQuest Ebook Central affiliated libraries.
650 0 _aUrinary organs--Diseases.
655 4 _aElectronic books.
700 1 _aPrzydacz, Mikolaj.
776 0 8 _iPrint version:
_aCorcos, Jacques
_tConsultation in Neurourology
_dCham : Springer International Publishing AG,c2017
_z9783319639093
797 2 _aProQuest (Firm)
856 4 0 _uhttps://ebookcentral.proquest.com/lib/orpp/detail.action?docID=5087769
_zClick to View
999 _c131187
_d131187